Apricot Capital
Venture capitalShanghai Β· 1 people tracked
Investment thesis
Connects China biotech to global pharma through proven licensing relationships (combined $45B) and offers founders deep clinical/pharma operational expertise via 20+ investment professionals, 300+ advisors, and experienced founder leadership.
Team Β· 1 people
from the firm's websiteInvestments Β· 19 tracked
founders shown can be your intro pathFrequently asked questions
- What sectors does Apricot Capital focus on?
- Apricot Capital focuses on Biotech, Consumer, EdTech, Medical Devices, PropTech.
- Where is Apricot Capital located?
- Apricot Capital is headquartered in Shanghai, CN.
- Does Apricot Capital lead rounds?
- Apricot Capital typically participates in rounds rather than leading them.
Similar investors
Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare, working alongside entrepreneurs from early to late-stage growth.
OMERS Ventures is the venture capital arm of the OMERS pension plan, investing in early-stage technology founders building solutions across North America and Europe.
Summit Partners is a growth investing firm that backs category-leading companies across technology, healthcare and life sciences, and growth products and services, providing capital and resources to support their expansion.
K3 Ventures presents itself as an investment platform focused on collaboration and partnership between founders and stakeholders, emphasizing trust, relevance, and long-term support.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups worldwide.